Elizabeth Alli to Anticarcinogenic Agents
This is a "connection" page, showing publications Elizabeth Alli has written about Anticarcinogenic Agents.
Connection Strength
0.028
-
Vinayak S, Schwartz EJ, Jensen K, Lipson J, Alli E, McPherson L, Fernandez AM, Sharma VB, Staton A, Mills MA, Schackmann EA, Telli ML, Kardashian A, Ford JM, Kurian AW. A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk. Breast Cancer Res Treat. 2013 Nov; 142(2):389-98.
Score: 0.028